Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Physiology|March 13, 2018
Key Inflammatory Processes in Human NASH Are Reflected in Ldlr-/-.Leiden Mice: A Translational Gene Profiling StudyMartine C Morrison, Robert Kleemann, Arianne van Koppen, et al.
Plos One|June 25, 2019
Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden miceKanita Salic, Robert Kleemann, Cynthia Wilkins-Port, et al.
BMC Systems Biology|September 11, 2014
Network signatures link hepatic effects of anti-diabetic interventions with systemic disease parametersThomas Kelder, Lars Verschuren, Ben van Ommen, et al.
Journal of Lipid Research|September 2, 2008
LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanismsLars Verschuren, Jitske de Vries-van der Weij, Susanne Zadelaar, et al.
Blood|October 24, 2002
Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formationRobert Kleemann, Philippe P Gervois, Lars Verschuren, et al.
Biology Open|April 27, 2019
Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patientsNaomichi Abe, Sayuka Kato, Takuma Tsuchida, et al.
Pharmacogenetics and Genomics|October 23, 2012
Systems biology analysis unravels the complementary action of combined rosuvastatin and ezetimibe therapyLars Verschuren, Marijana Radonjic, Peter Y Wielinga, et al.
Atherosclerosis|May 24, 2011
Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo modelsRobert Kleemann, Lars Verschuren, Martine Morrison, et al.
Antioxidants & Redox Signaling|August 24, 2005
Up-regulation and coexpression of MIF and matrix metalloproteinases in human abdominal aortic aneurysmsLars Verschuren, Jan H N Lindeman, J Hajo van Bockel, et al.
Atherosclerosis|May 30, 2016
Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatinKanita Salic, Martine C Morrison, Lars Verschuren, et al.
Pageof 9